Date Published: 3 November 2015
The Team Advising on The Case: Bill Jamieson and Amit Dhume.
CNPLaw LLP (“CNP”), formerly known as Colin Ng & Partners LLP, acted as Singapore counsel for Link Healthcare (“Link“), a specialist pharmaceutical and medical technology business focussed on the Asian, African and Australasian (“AAA“) regions, on the sale of Link to Clinigen Group plc (“Clinigen“), the speciality global pharmaceutical company listed in the UK, for an initial consideration of £44.5 million and a maximum of approximately £100 million based on achievement of milestones.
Clinigen agreed to acquire Link in late September 2015 and the acquisition was completed on 30 October 2015.
GENERAL DISCLAIMER
This article is provided to you for general information and should not be relied upon as legal advice. The editor and the contributing authors do not guarantee the accuracy of the contents and expressly disclaim any and all liability to any person in respect of the consequences of anything done or permitted to be done or omitted to be done wholly or partly in reliance upon the whole or any part of the contents.